Max $35,000 seed funding for 12 months starting January 1, 2023
Academic Council Faculty
Medical Center Line Faculty
Applications closed on October 3, 2022
Approximate Offer Date:
December 12th, 2022
The Dunlevie Maternal-Fetal Medicine (MFM) Center for Discovery, Innovation and Clinical Impact's mission is to empower an arc of discovery and implementation in maternal-fetal science. Aligned with this mission, the Center is offering a Fall 2022 Seed Grant opportunity with a funding period from January 1, 2023 - December 31, 2023.
Dunlevie MFM Center seed grants will be awarded to support any of the four focus areas which advance the maternal-fetal medicine science:
Basic Science Discovery
Prenatal Diagnosis and Fetal Therapy
Clinical Trials in Obstetrics and Maternal-Fetal Medicine
Eligible applicants must be Stanford faculty with University Medical Line (UML), University Tenure Line (UTL), Research (NTL-Research), Clinician Educator (CE), or Instructor position for the duration of the award.
Proposal is advancing the science of maternal-fetal medicine.
One submission allowed per applicant (as Principal Investigator), per cycle.
IRB or APLAC submission (if applicable) is required at time of proposal submission
Dunlevie MFM Center will request a report from the awardee at 6 months and at 12 months from the start of the project and then every year for the following two years (4 total progress reports), including all abstracts, presentations, publications, and grants (applied and/or funded) resulting from the work supported by the Center.
Maximum funding amount:
How can the funds be used?
Please refer to the attached instructions. Budget for the proposal should be constructed on the given budget template. Budget justification (max. 1 page) should be provided with a justification for all budgeted items.